Drug Type Antibody fusion proteins |
Synonyms- |
Mechanism FAP antagonists(Fibroblast activation protein alpha antagonists), TGF-β inhibitors(Transforming growth factor beta inhibitors), TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | CN | 08 Feb 2024 |